Search
  1. Home
  2. Africa
  • News

Once-a-day anti-AIDS pill show promise

    JOHANNESBURG

    A once-daily anti-AIDS treatment, the first of its kind, has been jointly developed by multinational drug firms Gilead and Bristol-Myers Squibb, and could soon outrun current three- times-a-day regimens.

    According to research published in the latest New England Journal of Medicine, the manufacturers found the new three-in-one drug especially effective in suppressing HIV viral loads and had fewer side effects than commonly used antiretrovirals.

    "I think it's a huge thing these companies are going to do ... with the right price in developing countries, the pill could become the main treatment for HIV in the world," Nelson Vergel, a US-based AIDS treatment activist, told the Washington Post.

    Gilead and Bristol-Myers Squibb hope to obtain US and European approval of the pill by the end of 2006.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join